Characterization of TIM-3 Expression and Its Correlation with TNF-α and IFN-γ in Patients with Surgically Resected Lung Adenocarcinoma. (21st February 2023)
- Record Type:
- Journal Article
- Title:
- Characterization of TIM-3 Expression and Its Correlation with TNF-α and IFN-γ in Patients with Surgically Resected Lung Adenocarcinoma. (21st February 2023)
- Main Title:
- Characterization of TIM-3 Expression and Its Correlation with TNF-α and IFN-γ in Patients with Surgically Resected Lung Adenocarcinoma
- Authors:
- Tan, Jian
Shen, Piao
Yang, Xingping
Cai, Weijie
Liao, Hongying - Other Names:
- Niu Xing Academic Editor.
- Abstract:
- Abstract : Objective . T cell immunoglobulin and mucin-containing protein-3 (TIM-3) is an important immune checkpoint, but its role in lung cancer is still not clear. In this study, we investigated TIM-3 protein expression and its correlation with TNF- α and IFN- γ by examining the tissues of patients with lung adenocarcinoma. Methods . We detected the mRNA quantity of TIM-3, TNF- α, and IFN- γ in 40 surgically resected specimens from patients with lung adenocarcinoma by real-time quantitative polymerase chain reaction (qRT-PCR). The protein expression of TIM-3, TNF- α, and IFN- γ was assessed in normal tissues, paracarcinoma tissues, and tumor tissues by western blotting, respectively. The relevance between the expression and clinicopathological information of the patients was analyzed. Results . The results showed that the expression level of TIM-3 was higher in tumor tissues than normal tissues and paracancerous tissues (P < 0.05 ). On the contrary, the expression of TNF- α and IFN- γ in tumor tissues was lower than normal tissues and paracarcinoma tissues (P < 0.05 ). However, the expression levels of IFN- γ mRNA were not observed to be significantly different between cancerous tissues and adjacent tissues. While TIM-3 protein expression in cancer tissues of patients with lymph node metastasis was higher than in patients without metastasis, the expression of TNF- α and IFN- γ was lower (P < 0.05 ). Importantly, the expression of TIM-3 was negatively correlated with theAbstract : Objective . T cell immunoglobulin and mucin-containing protein-3 (TIM-3) is an important immune checkpoint, but its role in lung cancer is still not clear. In this study, we investigated TIM-3 protein expression and its correlation with TNF- α and IFN- γ by examining the tissues of patients with lung adenocarcinoma. Methods . We detected the mRNA quantity of TIM-3, TNF- α, and IFN- γ in 40 surgically resected specimens from patients with lung adenocarcinoma by real-time quantitative polymerase chain reaction (qRT-PCR). The protein expression of TIM-3, TNF- α, and IFN- γ was assessed in normal tissues, paracarcinoma tissues, and tumor tissues by western blotting, respectively. The relevance between the expression and clinicopathological information of the patients was analyzed. Results . The results showed that the expression level of TIM-3 was higher in tumor tissues than normal tissues and paracancerous tissues (P < 0.05 ). On the contrary, the expression of TNF- α and IFN- γ in tumor tissues was lower than normal tissues and paracarcinoma tissues (P < 0.05 ). However, the expression levels of IFN- γ mRNA were not observed to be significantly different between cancerous tissues and adjacent tissues. While TIM-3 protein expression in cancer tissues of patients with lymph node metastasis was higher than in patients without metastasis, the expression of TNF- α and IFN- γ was lower (P < 0.05 ). Importantly, the expression of TIM-3 was negatively correlated with the expression of TNF- α and IFN- γ, and the expression of TNF- α was found to be positively correlated with IFN- γ in the patient. Conclusion . The high expression of TIM-3, the low expression of TNF- α and IFN- γ, and the synergistic effect of TNF- α and IFN- γ in patients with lung adenocarcinoma were closely related to poor clinicopathological characteristics. Overexpression of TIM-3 may play an important role in the relationship between TNF- α and IFN- γ secretion and poor clinicopathological characteristics. … (more)
- Is Part Of:
- Disease markers. Volume 2023(2023)
- Journal:
- Disease markers
- Issue:
- Volume 2023(2023)
- Issue Display:
- Volume 2023, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 2023
- Issue:
- 2023
- Issue Sort Value:
- 2023-2023-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-02-21
- Subjects:
- Diagnosis -- Periodicals
Biochemical markers -- Periodicals
Pathology -- Periodicals
616 - Journal URLs:
- https://www.hindawi.com/journals/dm/ ↗
- DOI:
- 10.1155/2023/2352945 ↗
- Languages:
- English
- ISSNs:
- 0278-0240
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 26141.xml